Wealthspire Advisors (New York)’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,624
Closed -$273K 1081
2025
Q4
$273K Buy
5,624
+5,132
+1,043% +$254K ﹤0.01% 844
2025
Q3
$23.2K Buy
+492
New +$23.7K ﹤0.01% 1608
2021
Q2
Sell
-10,121
Closed -$501K 616
2021
Q1
$501K Buy
10,121
+2,370
+31% +$114K 0.01% 398
2020
Q4
$377K Buy
7,751
+2,862
+59% +$141K 0.01% 366
2020
Q3
$245K Sell
4,889
-567
-10% -$29.2K 0.01% 263
2020
Q2
$279K Sell
5,456
-7,660
-58% -$372K 0.02% 216
2020
Q1
$573K Buy
13,116
+3,773
+40% +$181K 0.02% 273
2019
Q4
$469K Buy
9,343
+664
+8% +$31.1K 0.03% 107
2019
Q3
$402K Buy
8,679
+2,119
+32% +$91.4K 0.03% 96
2019
Q2
$284K Buy
+6,560
New +$279K 0.02% 76
2019
Q1
Sell
-1,538
Closed -$67K 676
2018
Q4
$67K Buy
+1,538
New +$67.8K 0.01% 154

Other funds holding SNY

Wealthspire Advisors (New York)'s SNY Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Sanofi (SNY) in Q1 2026, closing a stake of 5,624 shares — an estimated $273K sold.

Wealthspire Advisors (New York) first reported a position in SNY in Q4 2018 and held it in 11 quarters. The position peaked at $573K in Q1 2020. 740 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 5,624 Sanofi shares in Q1 2026, an estimated $273K.
  • Wealthspire Advisors (New York) first reported a position in Sanofi in Q4 2018 and held it in 11 quarters.
  • Wealthspire Advisors (New York)'s Sanofi position peaked at $573K in Q1 2020.
  • 740 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.